Plasma Protease C1-inhibitor Treatment Market
Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Plasma Protease C1-inhibitor Treatment
1.2 Key Market Segments
1.2.1 Plasma Protease C1-inhibitor Treatment Segment by Type
1.2.2 Plasma Protease C1-inhibitor Treatment Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Plasma Protease C1-inhibitor Treatment Market Overview
2.1 Global Market Overview
2.1.1 Global Plasma Protease C1-inhibitor Treatment Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Plasma Protease C1-inhibitor Treatment Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Plasma Protease C1-inhibitor Treatment Market Competitive Landscape
3.1 Global Plasma Protease C1-inhibitor Treatment Sales by Manufacturers (2019-2024)
3.2 Global Plasma Protease C1-inhibitor Treatment Revenue Market Share by Manufacturers (2019-2024)
3.3 Plasma Protease C1-inhibitor Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Plasma Protease C1-inhibitor Treatment Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Plasma Protease C1-inhibitor Treatment Sales Sites, Area Served, Product Type
3.6 Plasma Protease C1-inhibitor Treatment Market Competitive Situation and Trends
3.6.1 Plasma Protease C1-inhibitor Treatment Market Concentration Rate
3.6.2 Global 5 and 10 Largest Plasma Protease C1-inhibitor Treatment Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Plasma Protease C1-inhibitor Treatment Industry Chain Analysis
4.1 Plasma Protease C1-inhibitor Treatment Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Plasma Protease C1-inhibitor Treatment Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Plasma Protease C1-inhibitor Treatment Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Plasma Protease C1-inhibitor Treatment Sales Market Share by Type (2019-2024)
6.3 Global Plasma Protease C1-inhibitor Treatment Market Size Market Share by Type (2019-2024)
6.4 Global Plasma Protease C1-inhibitor Treatment Price by Type (2019-2024)
7 Plasma Protease C1-inhibitor Treatment Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Plasma Protease C1-inhibitor Treatment Market Sales by Application (2019-2024)
7.3 Global Plasma Protease C1-inhibitor Treatment Market Size (M USD) by Application (2019-2024)
7.4 Global Plasma Protease C1-inhibitor Treatment Sales Growth Rate by Application (2019-2024)
8 Plasma Protease C1-inhibitor Treatment Market Segmentation by Region
8.1 Global Plasma Protease C1-inhibitor Treatment Sales by Region
8.1.1 Global Plasma Protease C1-inhibitor Treatment Sales by Region
8.1.2 Global Plasma Protease C1-inhibitor Treatment Sales Market Share by Region
8.2 North America
8.2.1 North America Plasma Protease C1-inhibitor Treatment Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Plasma Protease C1-inhibitor Treatment Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Plasma Protease C1-inhibitor Treatment Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Plasma Protease C1-inhibitor Treatment Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Plasma Protease C1-inhibitor Treatment Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profile
9.1 Takeda
9.1.1 Takeda Plasma Protease C1-inhibitor Treatment Basic Information
9.1.2 Takeda Plasma Protease C1-inhibitor Treatment Product Overview
9.1.3 Takeda Plasma Protease C1-inhibitor Treatment Product Market Performance
9.1.4 Takeda Business Overview
9.1.5 Takeda Plasma Protease C1-inhibitor Treatment SWOT Analysis
9.1.6 Takeda Recent Developments
9.2 CSL
9.2.1 CSL Plasma Protease C1-inhibitor Treatment Basic Information
9.2.2 CSL Plasma Protease C1-inhibitor Treatment Product Overview
9.2.3 CSL Plasma Protease C1-inhibitor Treatment Product Market Performance
9.2.4 CSL Business Overview
9.2.5 CSL Plasma Protease C1-inhibitor Treatment SWOT Analysis
9.2.6 CSL Recent Developments
9.3 Sanquin
9.3.1 Sanquin Plasma Protease C1-inhibitor Treatment Basic Information
9.3.2 Sanquin Plasma Protease C1-inhibitor Treatment Product Overview
9.3.3 Sanquin Plasma Protease C1-inhibitor Treatment Product Market Performance
9.3.4 Sanquin Plasma Protease C1-inhibitor Treatment SWOT Analysis
9.3.5 Sanquin Business Overview
9.3.6 Sanquin Recent Developments
9.4 Pharming Group
9.4.1 Pharming Group Plasma Protease C1-inhibitor Treatment Basic Information
9.4.2 Pharming Group Plasma Protease C1-inhibitor Treatment Product Overview
9.4.3 Pharming Group Plasma Protease C1-inhibitor Treatment Product Market Performance
9.4.4 Pharming Group Business Overview
9.4.5 Pharming Group Recent Developments
10 Plasma Protease C1-inhibitor Treatment Market Forecast by Region
10.1 Global Plasma Protease C1-inhibitor Treatment Market Size Forecast
10.2 Global Plasma Protease C1-inhibitor Treatment Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Plasma Protease C1-inhibitor Treatment Market Size Forecast by Country
10.2.3 Asia Pacific Plasma Protease C1-inhibitor Treatment Market Size Forecast by Region
10.2.4 South America Plasma Protease C1-inhibitor Treatment Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Plasma Protease C1-inhibitor Treatment by Country
11 Forecast Market by Type and by Application (2025-2030)
11.1 Global Plasma Protease C1-inhibitor Treatment Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Plasma Protease C1-inhibitor Treatment by Type (2025-2030)
11.1.2 Global Plasma Protease C1-inhibitor Treatment Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Plasma Protease C1-inhibitor Treatment by Type (2025-2030)
11.2 Global Plasma Protease C1-inhibitor Treatment Market Forecast by Application (2025-2030)
11.2.1 Global Plasma Protease C1-inhibitor Treatment Sales (K Units) Forecast by Application
11.2.2 Global Plasma Protease C1-inhibitor Treatment Market Size (M USD) Forecast by Application (2025-2030)
12 Conclusion and Key Findings
List of Tables
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Plasma Protease C1-inhibitor Treatment Market Size Comparison by Region (M USD)
Table 5. Global Plasma Protease C1-inhibitor Treatment Sales (K Units) by Manufacturers (2019-2024)
Table 6. Global Plasma Protease C1-inhibitor Treatment Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Plasma Protease C1-inhibitor Treatment Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Plasma Protease C1-inhibitor Treatment Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Plasma Protease C1-inhibitor Treatment as of 2022)
Table 10. Global Market Plasma Protease C1-inhibitor Treatment Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Plasma Protease C1-inhibitor Treatment Sales Sites and Area Served
Table 12. Manufacturers Plasma Protease C1-inhibitor Treatment Product Type
Table 13. Global Plasma Protease C1-inhibitor Treatment Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Plasma Protease C1-inhibitor Treatment
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Plasma Protease C1-inhibitor Treatment Market Challenges
Table 22. Global Plasma Protease C1-inhibitor Treatment Sales by Type (K Units)
Table 23. Global Plasma Protease C1-inhibitor Treatment Market Size by Type (M USD)
Table 24. Global Plasma Protease C1-inhibitor Treatment Sales (K Units) by Type (2019-2024)
Table 25. Global Plasma Protease C1-inhibitor Treatment Sales Market Share by Type (2019-2024)
Table 26. Global Plasma Protease C1-inhibitor Treatment Market Size (M USD) by Type (2019-2024)
Table 27. Global Plasma Protease C1-inhibitor Treatment Market Size Share by Type (2019-2024)
Table 28. Global Plasma Protease C1-inhibitor Treatment Price (USD/Unit) by Type (2019-2024)
Table 29. Global Plasma Protease C1-inhibitor Treatment Sales (K Units) by Application
Table 30. Global Plasma Protease C1-inhibitor Treatment Market Size by Application
Table 31. Global Plasma Protease C1-inhibitor Treatment Sales by Application (2019-2024) & (K Units)
Table 32. Global Plasma Protease C1-inhibitor Treatment Sales Market Share by Application (2019-2024)
Table 33. Global Plasma Protease C1-inhibitor Treatment Sales by Application (2019-2024) & (M USD)
Table 34. Global Plasma Protease C1-inhibitor Treatment Market Share by Application (2019-2024)
Table 35. Global Plasma Protease C1-inhibitor Treatment Sales Growth Rate by Application (2019-2024)
Table 36. Global Plasma Protease C1-inhibitor Treatment Sales by Region (2019-2024) & (K Units)
Table 37. Global Plasma Protease C1-inhibitor Treatment Sales Market Share by Region (2019-2024)
Table 38. North America Plasma Protease C1-inhibitor Treatment Sales by Country (2019-2024) & (K Units)
Table 39. Europe Plasma Protease C1-inhibitor Treatment Sales by Country (2019-2024) & (K Units)
Table 40. Asia Pacific Plasma Protease C1-inhibitor Treatment Sales by Region (2019-2024) & (K Units)
Table 41. South America Plasma Protease C1-inhibitor Treatment Sales by Country (2019-2024) & (K Units)
Table 42. Middle East and Africa Plasma Protease C1-inhibitor Treatment Sales by Region (2019-2024) & (K Units)
Table 43. Takeda Plasma Protease C1-inhibitor Treatment Basic Information
Table 44. Takeda Plasma Protease C1-inhibitor Treatment Product Overview
Table 45. Takeda Plasma Protease C1-inhibitor Treatment Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 46. Takeda Business Overview
Table 47. Takeda Plasma Protease C1-inhibitor Treatment SWOT Analysis
Table 48. Takeda Recent Developments
Table 49. CSL Plasma Protease C1-inhibitor Treatment Basic Information
Table 50. CSL Plasma Protease C1-inhibitor Treatment Product Overview
Table 51. CSL Plasma Protease C1-inhibitor Treatment Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 52. CSL Business Overview
Table 53. CSL Plasma Protease C1-inhibitor Treatment SWOT Analysis
Table 54. CSL Recent Developments
Table 55. Sanquin Plasma Protease C1-inhibitor Treatment Basic Information
Table 56. Sanquin Plasma Protease C1-inhibitor Treatment Product Overview
Table 57. Sanquin Plasma Protease C1-inhibitor Treatment Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 58. Sanquin Plasma Protease C1-inhibitor Treatment SWOT Analysis
Table 59. Sanquin Business Overview
Table 60. Sanquin Recent Developments
Table 61. Pharming Group Plasma Protease C1-inhibitor Treatment Basic Information
Table 62. Pharming Group Plasma Protease C1-inhibitor Treatment Product Overview
Table 63. Pharming Group Plasma Protease C1-inhibitor Treatment Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 64. Pharming Group Business Overview
Table 65. Pharming Group Recent Developments
Table 66. Global Plasma Protease C1-inhibitor Treatment Sales Forecast by Region (2025-2030) & (K Units)
Table 67. Global Plasma Protease C1-inhibitor Treatment Market Size Forecast by Region (2025-2030) & (M USD)
Table 68. North America Plasma Protease C1-inhibitor Treatment Sales Forecast by Country (2025-2030) & (K Units)
Table 69. North America Plasma Protease C1-inhibitor Treatment Market Size Forecast by Country (2025-2030) & (M USD)
Table 70. Europe Plasma Protease C1-inhibitor Treatment Sales Forecast by Country (2025-2030) & (K Units)
Table 71. Europe Plasma Protease C1-inhibitor Treatment Market Size Forecast by Country (2025-2030) & (M USD)
Table 72. Asia Pacific Plasma Protease C1-inhibitor Treatment Sales Forecast by Region (2025-2030) & (K Units)
Table 73. Asia Pacific Plasma Protease C1-inhibitor Treatment Market Size Forecast by Region (2025-2030) & (M USD)
Table 74. South America Plasma Protease C1-inhibitor Treatment Sales Forecast by Country (2025-2030) & (K Units)
Table 75. South America Plasma Protease C1-inhibitor Treatment Market Size Forecast by Country (2025-2030) & (M USD)
Table 76. Middle East and Africa Plasma Protease C1-inhibitor Treatment Consumption Forecast by Country (2025-2030) & (Units)
Table 77. Middle East and Africa Plasma Protease C1-inhibitor Treatment Market Size Forecast by Country (2025-2030) & (M USD)
Table 78. Global Plasma Protease C1-inhibitor Treatment Sales Forecast by Type (2025-2030) & (K Units)
Table 79. Global Plasma Protease C1-inhibitor Treatment Market Size Forecast by Type (2025-2030) & (M USD)
Table 80. Global Plasma Protease C1-inhibitor Treatment Price Forecast by Type (2025-2030) & (USD/Unit)
Table 81. Global Plasma Protease C1-inhibitor Treatment Sales (K Units) Forecast by Application (2025-2030)
Table 82. Global Plasma Protease C1-inhibitor Treatment Market Size Forecast by Application (2025-2030) & (M USD)
List of Figures
Figure 1. Product Picture of Plasma Protease C1-inhibitor Treatment
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Plasma Protease C1-inhibitor Treatment Market Size (M USD), 2019-2030
Figure 5. Global Plasma Protease C1-inhibitor Treatment Market Size (M USD) (2019-2030)
Figure 6. Global Plasma Protease C1-inhibitor Treatment Sales (K Units) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Plasma Protease C1-inhibitor Treatment Market Size by Country (M USD)
Figure 11. Plasma Protease C1-inhibitor Treatment Sales Share by Manufacturers in 2023
Figure 12. Global Plasma Protease C1-inhibitor Treatment Revenue Share by Manufacturers in 2023
Figure 13. Plasma Protease C1-inhibitor Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Plasma Protease C1-inhibitor Treatment Average Price (USD/Unit) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Plasma Protease C1-inhibitor Treatment Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Plasma Protease C1-inhibitor Treatment Market Share by Type
Figure 18. Sales Market Share of Plasma Protease C1-inhibitor Treatment by Type (2019-2024)
Figure 19. Sales Market Share of Plasma Protease C1-inhibitor Treatment by Type in 2023
Figure 20. Market Size Share of Plasma Protease C1-inhibitor Treatment by Type (2019-2024)
Figure 21. Market Size Market Share of Plasma Protease C1-inhibitor Treatment by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Plasma Protease C1-inhibitor Treatment Market Share by Application
Figure 24. Global Plasma Protease C1-inhibitor Treatment Sales Market Share by Application (2019-2024)
Figure 25. Global Plasma Protease C1-inhibitor Treatment Sales Market Share by Application in 2023
Figure 26. Global Plasma Protease C1-inhibitor Treatment Market Share by Application (2019-2024)
Figure 27. Global Plasma Protease C1-inhibitor Treatment Market Share by Application in 2023
Figure 28. Global Plasma Protease C1-inhibitor Treatment Sales Growth Rate by Application (2019-2024)
Figure 29. Global Plasma Protease C1-inhibitor Treatment Sales Market Share by Region (2019-2024)
Figure 30. North America Plasma Protease C1-inhibitor Treatment Sales and Growth Rate (2019-2024) & (K Units)
Figure 31. North America Plasma Protease C1-inhibitor Treatment Sales Market Share by Country in 2023
Figure 32. U.S. Plasma Protease C1-inhibitor Treatment Sales and Growth Rate (2019-2024) & (K Units)
Figure 33. Canada Plasma Protease C1-inhibitor Treatment Sales (K Units) and Growth Rate (2019-2024)
Figure 34. Mexico Plasma Protease C1-inhibitor Treatment Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Plasma Protease C1-inhibitor Treatment Sales and Growth Rate (2019-2024) & (K Units)
Figure 36. Europe Plasma Protease C1-inhibitor Treatment Sales Market Share by Country in 2023
Figure 37. Germany Plasma Protease C1-inhibitor Treatment Sales and Growth Rate (2019-2024) & (K Units)
Figure 38. France Plasma Protease C1-inhibitor Treatment Sales and Growth Rate (2019-2024) & (K Units)
Figure 39. U.K. Plasma Protease C1-inhibitor Treatment Sales and Growth Rate (2019-2024) & (K Units)
Figure 40. Italy Plasma Protease C1-inhibitor Treatment Sales and Growth Rate (2019-2024) & (K Units)
Figure 41. Russia Plasma Protease C1-inhibitor Treatment Sales and Growth Rate (2019-2024) & (K Units)
Figure 42. Asia Pacific Plasma Protease C1-inhibitor Treatment Sales and Growth Rate (K Units)
Figure 43. Asia Pacific Plasma Protease C1-inhibitor Treatment Sales Market Share by Region in 2023
Figure 44. China Plasma Protease C1-inhibitor Treatment Sales and Growth Rate (2019-2024) & (K Units)
Figure 45. Japan Plasma Protease C1-inhibitor Treatment Sales and Growth Rate (2019-2024) & (K Units)
Figure 46. South Korea Plasma Protease C1-inhibitor Treatment Sales and Growth Rate (2019-2024) & (K Units)
Figure 47. India Plasma Protease C1-inhibitor Treatment Sales and Growth Rate (2019-2024) & (K Units)
Figure 48. Southeast Asia Plasma Protease C1-inhibitor Treatment Sales and Growth Rate (2019-2024) & (K Units)
Figure 49. South America Plasma Protease C1-inhibitor Treatment Sales and Growth Rate (K Units)
Figure 50. South America Plasma Protease C1-inhibitor Treatment Sales Market Share by Country in 2023
Figure 51. Brazil Plasma Protease C1-inhibitor Treatment Sales and Growth Rate (2019-2024) & (K Units)
Figure 52. Argentina Plasma Protease C1-inhibitor Treatment Sales and Growth Rate (2019-2024) & (K Units)
Figure 53. Columbia Plasma Protease C1-inhibitor Treatment Sales and Growth Rate (2019-2024) & (K Units)
Figure 54. Middle East and Africa Plasma Protease C1-inhibitor Treatment Sales and Growth Rate (K Units)
Figure 55. Middle East and Africa Plasma Protease C1-inhibitor Treatment Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Plasma Protease C1-inhibitor Treatment Sales and Growth Rate (2019-2024) & (K Units)
Figure 57. UAE Plasma Protease C1-inhibitor Treatment Sales and Growth Rate (2019-2024) & (K Units)
Figure 58. Egypt Plasma Protease C1-inhibitor Treatment Sales and Growth Rate (2019-2024) & (K Units)
Figure 59. Nigeria Plasma Protease C1-inhibitor Treatment Sales and Growth Rate (2019-2024) & (K Units)
Figure 60. South Africa Plasma Protease C1-inhibitor Treatment Sales and Growth Rate (2019-2024) & (K Units)
Figure 61. Global Plasma Protease C1-inhibitor Treatment Sales Forecast by Volume (2019-2030) & (K Units)
Figure 62. Global Plasma Protease C1-inhibitor Treatment Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Plasma Protease C1-inhibitor Treatment Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Plasma Protease C1-inhibitor Treatment Market Share Forecast by Type (2025-2030)
Figure 65. Global Plasma Protease C1-inhibitor Treatment Sales Forecast by Application (2025-2030)
Figure 66. Global Plasma Protease C1-inhibitor Treatment Market Share Forecast by Application (2025-2030)
Industry Market Size
